MOUNTAIN VIEW, Calif., Feb. 3, 2016 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: OMCL) today announced that The University of Kansas Hospital has selected the Company's medication management automation and software across their multi-center health system, with installation expected to begin in the summer of 2016. Omnicell's automated technology and software is intended to streamline hospital workflow through seamless interoperability with the hospital's Epic electronic health record (EHR) system while enhancing inventory management and maintaining the highest level of patient safety.

Omnicell, Inc. logo.

In selecting a new automation provider, The University of Kansas Hospital sought to increase medication dispensing efficiency, maintain patient safety on the patient floors and in the operating room, and streamline workflows for nurses and pharmacists. Following a four-month evaluation process that included hands-on demonstrations, consultations with current users and meetings with hospital leaders and staff, a multidisciplinary evaluation committee representing nurses, pharmacists and informaticists selected Omnicell's solutions. The University of Kansas Hospital will be installing Omnicell's central pharmacy automation, medication management and analytics solutions designed to increase staff efficiencies as well as provide outstanding patient care.

"With a project scope as large as ours, we needed a partner who would work with us. Ensuring that all of our facilities are working in concert to improve patient safety while reducing administrative burden was also a major goal," said Christopher Bell, MS, PharmD, pharmacy assistant director at The University of Kansas Hospital. "We're excited to work with Omnicell to achieve these goals, and anticipate that their Unity single server platform will allow us valuable inventory transparency across facilities in our health system."

Bell continued, "Omnicell offers us the level of interoperability with our EHR that would allow our nurses to queue up medications anywhere, enabling them to spend more time on direct patient care activities."

"The opportunity to extend Omnicell solutions across The University of Kansas Hospital's health system is an exciting prospect as our company enters 2016," said J. Christopher Drew, executive vice president, sales and marketing at Omnicell. "We are proud to be selected as a partner by a premier Magnet-recognized academic medical institution, and are eager to support their efforts in advancing their high standards for patient care and facility workflow."

About The University of Kansas Hospital

The University of Kansas Hospital is the region's premier academic medical center, providing a full range of care. The hospital is affiliated with the University of Kansas Schools of Medicine, Nursing and Health Professions, and their various leading-edge research projects. The constantly growing facility contains 746 staffed beds (plus 24 bassinets) and serves more than 31,000 inpatients annually. Twelve of its medical and surgical specialty areas are ranked nationally by the U.S. News & World Report "Best Hospital" lists, including Cancer (#29), Cardiology & Heart Surgery (#21), Diabetes & Endocrinology (#20), Ear, Nose & Throat (#17), Gastroenterology and GI Surgery (#24), Geriatrics (#16), Gynecology (#38), Nephrology (#33), Neurology & Neurosurgery (#12), Orthopedics (#33-Tied), Pulmonology (#12) and Urology (#36). The cancer program is part of The University of Kansas Cancer Center, a National Cancer Institute-designated program. The hospital has received Magnet nursing designation, reflecting the quality of care throughout the hospital, an honor awarded to only 6.6 percent of the hospitals nationwide. The hospital also houses the region's only accredited burn center, the area's only nationally accredited Level I Trauma Center and the area's first Advanced Comprehensive Stroke Center recognized by The Joint Commission. For more information, visit kumed.com.

About Omnicell

Since 1992, Omnicell (NASDAQ: OMCL) has been creating innovative solutions to improve patient care, anywhere it is delivered. Omnicell is a leading supplier of comprehensive automation and business analytics software for medication and supply management across the entire health care continuum—from the acute care hospital setting, to post-acute skilled nursing and long-term care facilities, to the patient's home.

Approximately 4,000 customers worldwide use Omnicell automation and analytics solutions to increase operational efficiency, reduce medication errors, deliver actionable intelligence and improve patient safety. The recent acquisition of Aesynt adds distinct capabilities, particularly in central pharmacy and IV robotics, creating the broadest medication management product portfolio in the industry.

The Omnicell SureMed solution provides innovative medication adherence packaging to help reduce costly hospital readmissions. In addition, these solutions enable approximately 7,000 institutional and retail pharmacies worldwide to maintain high accuracy and quality standards in medication dispensing and administration while optimizing productivity and controlling costs.

For more information about Omnicell, Inc. please visit www.omnicell.com.

OMCL-G

Editor's Notes:

  1. All Omnicell news releases (financial, acquisitions, products, technology etc.) are issued exclusively by PR Newswire and are immediately thereafter posted on the company's external website, omnicell.com.
  2. Omnicell and the Omnicell logo design are registered trademarks of Omnicell, Inc.
  3. All other brand or product names may be trademarks or registered trademarks of their respective companies.

Logo - http://photos.prnewswire.com/prnh/20120731/SF48971LOGO-a

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/the-university-of-kansas-hospital-selects-omnicell-automation-solutions-to-advance-patient-safety-and-efficiency-300214163.html

SOURCE Omnicell, Inc.

Copyright 2016 PR Newswire

Omnicell (NASDAQ:OMCL)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Omnicell Charts.
Omnicell (NASDAQ:OMCL)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Omnicell Charts.